A New C-Xyloside Induces Modifications of GAG Expression, Structure and Functional Properties

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Vassal Stermann, Emilie ^a   Duranton, Albert ^b   Black, Annie F ^b   Azadiguian, Gayane ^b   Demaude, Julien ^b   Lortat Jacob, Hugues ^a   Breton, Lionel ^b   Vivès, Romain R ^a  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b L ORÉAL RECHERCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C XYLOSIDE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; MEMBRANE PROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIC STRENGTH; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SULFATION;

CHONDROITIN; CHROMATOGRAPHY, GEL; DERMATAN SULFATE; DERMIS; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; GLYCOSIDES; HEPATOCYTE GROWTH FACTOR; HUMANS; SCINTILLATION COUNTING; TRITIUM;

EID: 84868143070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047933     Document Type: Article

References (46)

1. Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 3. doi: 10.1101/cshperspect.a004952.
2. Spillmann D, (2001) Heparan sulfate: anchor for viral intruders? Biochimie 83: 811-817.
3. Delehedde M, Allain F, Payne SJ, Borgo R, Vampouille C, et al. (2002) Proteoglycans in Inflammation. Curr Med Chem 1: 89-102.
4. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U, (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2: 521-528.
5. Esko JD, Kimata K, Lindahl U (2009) Proteoglycans and Sulfated Glycosaminoglycans. In: Varki A CR, Esko JD, Freeze H, Hart G, Marth J, editor. Essentials of Glycobiology 2nd edition. Cold Spring Harbor Laboratory Press.
6. Lindahl U, Li JP, (2009) Interactions between heparan sulfate and proteins-design and functional implications. Int Rev Cell Mol Biol 276: 105-159.
7. Zhang L, (2010) Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins. Prog Mol Biol Transl Sci 93: 1-17.
8. Esko JD, Lindahl U, (2001) Molecular diversity of heparan sulfate. J Clin Invest 108: 169-173.
9. Zhang L, Esko JD, (1994) Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J Biol Chem 269: 19295-19299.
10. Ueno M, Yamada S, Zako M, Bernfield M, Sugahara K, (2001) Structural characterization of heparan sulfate and chondroitin sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence. J Biol Chem 276: 29134-29140.
11. Gulberti S, Lattard V, Fondeur M, Jacquinet JC, Mulliert G, et al. (2005) Phosphorylation and sulfation of oligosaccharide substrates critically influence the activity of human beta1,4-galactosyltransferase 7 (GalT-I) and beta1,3-glucuronosyltransferase I (GlcAT-I) involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem 280: 1417-1425.
12. Kuberan B, Ethirajan M, Victor XV, Tran V, Nguyen K, et al. (2008) "Click" xylosides initiate glycosaminoglycan biosynthesis in a mammalian cell line. Chembiochem 9: 198-200.
13. Lugemwa FN, Sarkar AK, Esko JD, (1996) Unusual beta-D-xylosides that prime glycosaminoglycans in animal cells. J Biol Chem 271: 19159-19165.
14. Prydz K, Vuong TT, Kolset SO, (2009) Glycosaminoglycan secretion in xyloside treated polarized human colon carcinoma Caco-2 cells. Glycoconj J 26: 1117-1124.
15. Fritz TA, Lugemwa FN, Sarkar AK, Esko JD, (1994) Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure. J Biol Chem 269: 300-307.
16. Lugemwa FN, Esko JD, (1991) Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis. J Biol Chem 266: 6674-6677.
17. Bulow HE, Hobert O, (2006) The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol 22: 375-407.
18. Forsberg E, Kjellen L, (2001) Heparan sulfate: lessons from knockout mice. J Clin Invest 108: 175-180.
19. Kusche-Gullberg M, Kjellen L, (2003) Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 13: 605-611.
20. Miao HQ, Liu H, Navarro E, Kussie P, Zhu Z, (2006) Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem 13: 2101-2111.
21. Rosen SD, Lemjabbar-Alaoui H, (2010) Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets 14: 935-949.
22. Garud DR, Tran VM, Victor XV, Koketsu M, Kuberan B, (2008) Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis. J Biol Chem 283: 28881-28887.
23. Raman K, Ninomiya M, Nguyen TK, Tsuzuki Y, Koketsu M, et al. (2011) Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis. Biochem Biophys Res Commun 404: 86-89.
24. Tran VM, Victor XV, Yockman JW, Kuberan B, (2010) RGD-xyloside conjugates prime glycosaminoglycans. Glycoconj J 27: 625-633.
25. Pineau N, Carrino DA, Caplan AI, Breton L, (2011) Biological evaluation of a new C-xylopyranoside derivative (C-Xyloside) and its role in glycosaminoglycan biosynthesis. Eur J Dermatol 21: 359-370.
26. Cavezza A, Boulle C, Gueguiniat A, Pichaud P, Trouille S, et al. (2009) Synthesis of Pro-Xylane: a new biologically active C-glycoside in aqueous media. Bioorg Med Chem Lett 19: 845-849.
27. Pineau N, Bernerd F, Cavezza A, Dalko-Csiba M, Breton L, (2008) A new C-xylopyranoside derivative induces skin expression of glycosaminoglycans and heparan sulphate proteoglycans. Eur J Dermatol 18: 36-40.
28. Sok J, Pineau N, Dalko-Csiba M, Breton L, Bernerd F, (2008) Improvement of the dermal epidermal junction in human reconstructed skin by a new c-xylopyranoside derivative. Eur J Dermatol 18: 297-302.
29. Muto J, Naidu NN, Yamasaki K, Pineau N, Breton L, et al. (2011) Exogenous addition of a C-xylopyranoside derivative stimulates keratinocyte dermatan sulfate synthesis and promotes migration. PLoS One 6: e25480.
30. Wasteson A, (1971) A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J Chromatogr 59: 87-97.
31. Lyon M, Deakin JA, Gallagher JT, (1994) Liver heparan sulfate structure. A novel molecular design. J Biol Chem 269: 11208-11215.
32. Passi A, Albertini R, Campagnari F, De Luca G, (1997) Modifications of proteoglycans secreted into the growth medium by young and senescent human skin fibroblasts. FEBS Lett 402: 286-290.
33. Shin JE, Oh JH, Kim YK, Jung JY, Chung JH, (2011) Transcriptional regulation of proteoglycans and glycosaminoglycan chain-synthesizing glycosyltransferases by UV irradiation in cultured human dermal fibroblasts. J Korean Med Sci 26: 417-424.
34. Vuillermoz B, Wegrowski Y, Contet-Audonneau JL, Danoux L, Pauly G, et al. (2005) Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol Cell Biochem 277: 63-72.
35. Su X, Paris M, Gi YJ, Tsai KY, Cho MS, et al. (2009) TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 5: 64-75.
36. Takamiya M, Biwasaka H, Saigusa K, Nakayashiki N, Aoki Y, (2009) Wound age estimation by simultaneous detection of 9 cytokines in human dermal wounds with a multiplex bead-based immunoassay: an estimative method using outsourced examinations. Leg Med (Tokyo) 11: 186-190.
37. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF, (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
38. Mildner M, Mlitz V, Gruber F, Wojta J, Tschachler E, (2007) Hepatocyte growth factor establishes autocrine and paracrine feedback loops for the protection of skin cells after UV irradiation. J Invest Dermatol 127: 2637-2644.
39. Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, et al. (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279: 12346-12354.
40. Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, et al. (2008) Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 283: 5235-5248.
41. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT, (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem 269: 11216-11223.
42. Deakin JA, Blaum BS, Gallagher JT, Uhrin D, Lyon M, (2009) The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns. J Biol Chem 284: 6311-6321.
43. Bernerd F, Asselineau D, (1997) Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damages in skin reconstructed in vitro. Dev Biol 183: 123-138.
44. Black AF, Bouez C, Perrier E, Schlotmann K, Chapuis F, et al. (2005) Optimization and characterization of an engineered human skin equivalent. Tissue Eng 11: 723-733.
45. Hiscock DR, Canfield A, Gallagher JT, (1995) Molecular structure of heparan sulphate synthesised by bovine aortic endothelial cells. Biochim Biophys Acta 1244: 104-112.
46. Vives RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H, (2002) A Kinetics and Modeling Study of RANTES(9-68) Binding to Heparin Reveals a Mechanism of Cooperative Oligomerization. Biochemistry 41: 14779-14789.